Impact of depression on adherence to lenalidomide plus low-dose dexamethasone in patients with relapsed or refractory myeloma - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33575840/
Patients with depression had a substantially high risk of poor adherence compared to patients without depression. Given that Rd treatment is mainly offered by outpatient clinics, active interventions to reduce depression should be considered for MM patients prior to Rd treatment.
-
Mark FeslerMay 05, 2021Very important topic linking compliance and ultimately effectiveness of oral antineoplastic therapy with depression